Literature DB >> 12637467

Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.

Ajeet Gajra1, Nancy Newman, Gary P Gamble, Leslie J Kohman, Stephen L Graziano.   

Abstract

PURPOSE: We postulate that surgical sampling and pathologic evaluation of lymph nodes of surgical specimens from patients with stage I non-small-cell lung cancer (NSCLC) can have an effect on the time to recurrence and survival of these patients. PATIENTS AND METHODS: We analyzed data on 442 patients with stage I NSCLC who were treated with surgical resection and some form of lymph node sampling. Associations between total lymph nodes sampled and disease-free survival (DFS) and overall survival (OS) were investigated. The effect of total lymph node stations sampled and the surgical techniques (random lymph node sampling, systematic sampling [SS], or complete mediastinal lymph node dissection [MLND]) on DFS and OS was also studied. Complete MLND and SS were defined as dissection or sampling of levels 4, 7, and 10 for right-sided lesions and levels 5 or 6 and 7 for left-sided lesions.
RESULTS: Patients were divided into quartiles on the basis of total number of lymph nodes sampled. Improved DFS and OS were associated with greater number of lymph nodes sampled. SS and MLND were associated with improved survival compared with random lymph node sampling. The total number of lymph nodes sampled maintained strong significance in the multivariate analysis.
CONCLUSION: These results indicate that examining a greater number of lymph nodes in patients with stage I NSCLC treated with resection increases the likelihood of proper staging and affects patient outcome. Such information is important not only for therapy and prognosis of individuals but also for identifying those who may benefit from adjuvant therapy.

Entities:  

Mesh:

Year:  2003        PMID: 12637467     DOI: 10.1200/JCO.2003.07.010

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  82 in total

1.  Surgical staging of cancer: impact on prognosis and potential for bias in clinical trials.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

2.  Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Authors:  Chang-Li Wang; Yue Li; Dong-Sheng Yue; Lian-Min Zhang; Zhen-Fa Zhang; Bing-Sheng Sun
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Haruhisa Matsuguma; Izumi Oki; Rie Nakahara; Norihisa Ohata; Seiji Igarashi; Kiyoshi Mori; Shunsuke Endo; Kohei Yokoi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

4.  Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.

Authors:  Marc Riquet; Pierre Mordant
Journal:  Transl Lung Cancer Res       Date:  2013-02

Review 5.  Towards optimal pathologic staging of resectable non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Gail E Darling
Journal:  Transl Lung Cancer Res       Date:  2013-10

6.  Prognostic factors for surgically managed patients with stage II non-small cell lung cancer.

Authors:  Liming Wang; Yang Liu; Shun Xu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Examined lymph node count in non-small-cell lung cancer: will it be a decision making approach in treatment of NSCLC?

Authors:  Renwang Liu; Jun Chen; Song Xu
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

8.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08

9.  Relapse in resected lung cancer revisited: does intensified follow up really matter? A prospective study.

Authors:  Dragan Subotic; Dragan Mandaric; Gordana Radosavljevic; Jelena Stojsic; Milan Gajic; Maja Ercegovac
Journal:  World J Surg Oncol       Date:  2009-11-12       Impact factor: 2.754

10.  Does the extent of lymph nodes dissection affect the prognosis of resected stage IA non-small cell lung cancer?

Authors:  F Xu; C Wang; L Qi; W Yu; Q Li
Journal:  Clin Transl Oncol       Date:  2013-04-25       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.